\n
While lesion growth in geographic atrophy may appear to proceed slowly, disease progression is continuous and irreversible.<\/strong><\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div><\/div>\n\n\n\n\n
Geographic atrophy progression is continuous and irreversible.1\u20134<\/sup><\/h2>\n<\/div>\n\n\n
While lesion growth in geographic atrophy may appear to proceed slowly, disease progression is continuous and irreversible.<\/strong><\/p>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
<\/figure>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
\n
\n
Growth of GA lesions lead to visual impairment<\/strong>, even before lesion growth reaches the fovea.<\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div><\/div>\n\n\n\n\n
Geographic atrophy progression is continuous and irreversible.1\u20134<\/sup><\/h2>\n<\/div>\n\n\n
Growth of GA lesions lead to visual impairment<\/strong>, even before lesion growth reaches the fovea.<\/p>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
<\/figure>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
\n
\n
Of the 397 patients<\/strong> who developed central GA, the median time to foveal encroachment was only 2.5 years from diagnosis<\/strong>, according to a prospective AREDS study (N=3640).<\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div><\/div>\n\n\n\n\n
Geographic atrophy progression is continuous and irreversible.1\u20134<\/sup><\/h2>\n<\/div>\n\n\n
Of the 397 patients<\/strong> who developed central GA, the median time to foveal encroachment was only 2.5 years from diagnosis<\/strong>, according to a prospective AREDS study (N=3640).<\/p>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
<\/figure>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n
<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n
\n
\n
<\/div>\n<\/div>\n\n
\n
\n
\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Currently geographic atrophy affects more than 5 million people worldwide.1<\/sup><\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
From age 50, prevalence quadruples every 10 years.<\/strong>5<\/strong><\/sup><\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Geographic atrophy accounts for around 25% of all legal blindness <\/strong>attributed to AMD.6\u20138<\/sup><\/p>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n
\n
\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
An eye with geographic atrophy can also naturally develop wet AMD.9<\/sup><\/p>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
of patients with wet AMD progressed to geographic atrophy<\/strong> over an average of 7.3 years of follow-up.10<\/sup><\/p>\n<\/div><\/div>\n\n\n\n<\/div>\n<\/div>\n<\/div>\n\n
\n
<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n
\n
\n
<\/div>\n<\/div>\n\n
\n
Geographic atrophy is characterised by progressive and irreversible loss of the photoreceptors, retinal pigment epithelium (RPE) and underlying choriocapillaris.1,11<\/sup><\/h2>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Regions of atrophy typically start outside the fovea and expand to involve the fovea, which \u2013 over time \u2013 leads to permanent loss of vision.11<\/sup><\/p>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
\n
\n
<\/figure><\/div>\n\n\n
<\/div>\n<\/div>\n\n\n
Fundus photograph of a healthy eye<\/strong><\/p>\n<\/div>\n\n\n\n\n
<\/figure><\/div>\n\n\n
<\/div>\n<\/div>\n\n\n
Fundus photograph of an eye with geographic atrophy<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n
<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n
\n
\n
<\/div>\n<\/div>\n\n
\n
Causes of geographic atrophy<\/h2>\n<\/div>\n\n\n
Age-related macular degeneration is a complex, multifactorial disease and geographic atrophy pathogenesis encompasses a complex interaction of genetic, physiological and environmental factors.12\u201315<\/sup><\/p>\n<\/div>\n\n\n
\n
\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Genetics<\/strong><\/p>\n<\/div>\n\n\n
\n
Drusen formation<\/li>\n<\/div>\n\n\n
Formation of reactive oxygen species<\/li>\n<\/div>\n\n\n
Inflammation<\/li>\n<\/div>\n\n\n
Immune response, including complement<\/li>\n<\/div><\/ul>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Physiology<\/strong><\/p>\n<\/div>\n\n\n
\n
Age is the greatest risk factor for Geographic Atrophy<\/li>\n<\/div><\/ul>\n<\/div><\/div>\n\n\n\n\n
<\/figure>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
Environment<\/strong><\/p>\n<\/div>\n\n\n
\n
Sunlight, smoking and diet<\/li>\n<\/div>\n\n\n
High alcohol intake<\/li>\n<\/div><\/ul>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n
<\/div>\n<\/div><\/div>\n<\/div><\/div>\n\n
\n
\n
<\/div>\n<\/div>\n\n
\n
Lesion growth may lead to visual decline.1,12,13<\/sup><\/h2>\n<\/div>\n\n\n
Visual acuity does not strongly correlate with geographic atrophy lesion growth. Functional vision declines as lesions grow.14<\/sup><\/p>\n<\/div>\n\n\n
<\/div>\n<\/div>\n\n
\n
\n
\n
<\/figure>\n<\/div>\n\n\n
Baseline Year 1<\/strong><\/p>\n<\/div>\n\n\n
BCVA 20\/63+, GA Area 5.18 mm2<\/sup><\/p>\n<\/div><\/div>\n\n\n\n